NASDAQ: IRON

Disc Medicine, Inc.

Healthcare | Biotechnology

No licensed closing price on file for IRON. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Disc Medicine, Inc. (NASDAQ: IRON) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:34 UTC.

Key facts

Charts

Charts are in the appInteractive charts for IRON are available in Oxford Ledge.
Open IRON in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-09-16

2026-09-16Chief Executive OfficerStock Option (Right to Buy)Option exercise-36,000—
2026-09-16Chief Executive OfficerOption exercise36,000$36.4K
2026-09-15DirectorStock Option (Right to Buy)Option exercise-7,136—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

FMR LLC4,894,473$357.98M-10.6%
BlackRock, Inc.2,467,899$180.50M+8.5%
RA CAPITAL MANAGEMENT, L.P.2,450,221$179.21M0.0%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2024-02-07Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2023-10-23Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2023-04-19Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

Disc Medicine, Inc. (IRON) Discusses Topline Results of APOLLO Phase III Trial of Bitopertin in EPP Transcript
Seeking Alpha Feed2026-10-19
Disc Medicine's rare disease drug succeeds in late-stage trial
reuters.com2026-10-19
Disc Medicine posts late-stage trial win for lead asset developed with Roche
Seeking Alpha Markets2026-10-19
Disc Medicine rallies 32% as investors await bitopertin trial results
Seeking Alpha Markets2026-10-19
Premarket Movers Oct. 19: Disc Medicine Jumps 51.62%, Rubico Falls 33.84%
ChartMill2026-10-19NEG

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for IRON and 5,000+ tickers.

Create a free account — keep IRON

For your agent

GET /api/data?ticker=IRON

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt